 Cisplatin fluorouracil chemotherapy long-term benefit advanced head neck cancer results single institution patients head neck cancer cycles cisplatin continuous infusion fluorouracil induction chemotherapy Subsequent local therapy surgery patients resectable disease and/or radiotherapy cycles adjuvant chemotherapy patients partial response PR complete response CR induction chemotherapy Twenty-two patients clinical CR patients patients PR overall response rate Local therapy surgery patients patients Adjuvant chemotherapy patients great dose reduction median follow-up months median survival months confidence interval months survival patients alive disease-free time median time progression months patients progression head neck cancer progression second neoplasm patients medical events high incidence second malignancies continued investigation chemoprevention patients CR high response rates cisplatin induction chemotherapy overall poor survival data thorough reexamination frequent administration regimen community